Imaging of renal cell carcinoma.
暂无分享,去创建一个
[1] A. Belldegrun,et al. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial. , 2015, Urologic oncology.
[2] M. McInnes,et al. Multiparametric MRI of solid renal masses: pearls and pitfalls. , 2015, Clinical radiology.
[3] T. Bathala,et al. Intraoperative sonography during open partial nephrectomy for renal cell cancer: does it alter surgical management? , 2014, AJR. American journal of roentgenology.
[4] Z. Koc,et al. Optimal b value in diffusion‐weighted imaging for differentiation of abdominal lesions , 2014, Journal of magnetic resonance imaging : JMRI.
[5] Daniele Marin,et al. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. , 2014, Radiology.
[6] W. Horninger,et al. De novo Renal Cell Carcinoma in a Kidney Allograft with Focus on Contrast-Enhanced Ultrasound , 2014, Urologia Internationalis.
[7] N. Khandelwal,et al. Dynamic computed tomography and Doppler findings in different subtypes of renal cell carcinoma with their histopathological correlation. , 2014, Journal of cancer research and therapeutics.
[8] I. Pedrosa,et al. MRI Phenotype in Renal Cancer: Is It Clinically Relevant? , 2014, Topics in Magnetic Resonance Imaging (TMRI).
[9] Kyoung-Sik Cho,et al. Comparison of T2-weighted MRI with and without fat suppression for differentiating renal angiomyolipomas without visible fat from other renal tumors. , 2014, AJR. American journal of roentgenology.
[10] Cong Wang,et al. Diagnostic accuracy of contrast-enhanced ultrasound for renal cell carcinoma: a meta-analysis , 2014, Tumor Biology.
[11] J. Willatt,et al. MR imaging in the characterization of small renal masses , 2014, Abdominal Imaging.
[12] A. Ravaud,et al. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours , 2014, European Radiology.
[13] Seung Hyup Kim,et al. Usefulness of resistive index on spectral Doppler ultrasonography in the detection of renal cell carcinoma in patients with end-stage renal disease , 2014, Ultrasonography.
[14] J. Leyendecker,et al. Characterizing solid renal neoplasms with MRI in adults , 2014, Abdominal Imaging.
[15] P. Zondervan,et al. The Role of Imaging in the Active Surveillance of Small Renal Masses , 2014, Current Urology Reports.
[16] Josip Španjol,et al. Different Presentations of Renal Cell Cancer on Ultrasound and Computerized Tomography , 2014, Urologia.
[17] G. Israel,et al. MR imaging of the kidneys and adrenal glands. , 2014, Radiologic clinics of North America.
[18] J. Kim,et al. Can Initial 18F-FDG PET-CT Imaging Give Information on Metastasis in Patients with Primary Renal Cell Carcinoma? , 2013, Nuclear Medicine and Molecular Imaging.
[19] C. Kuhl,et al. Pilot study of non‐contrast‐enhanced MRI vs. ultrasound in renal transplant recipients with acquired cystic kidney disease: a prospective intra‐individual comparison , 2013, Clinical transplantation.
[20] C. Roy,et al. Small solid renal masses: characterization by diffusion-weighted MRI at 3 T. , 2013, Clinical radiology.
[21] Daniel Margolis,et al. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. , 2013, Radiology.
[22] Steven P. Larson,et al. Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Berthold Kiefer,et al. Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. , 2012, Radiology.
[24] Ivan Pedrosa,et al. Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. , 2012, Radiology.
[25] Sutchin R. Patel,et al. Renal cell carcinoma: attenuation values on unenhanced CT. , 2012, AJR. American journal of roentgenology.
[26] S. Wach,et al. Dynamic Tissue Perfusion Measurement: A New Tool for Characterizing Renal Perfusion in Renal Cell Carcinoma Patients , 2012, Urologia Internationalis.
[27] C. Kao,et al. Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma , 2012, Cancer imaging : the official publication of the International Cancer Imaging Society.
[28] E. Siegelman,et al. MR imaging of endometriosis: ten imaging pearls. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.
[29] B. Leibovich,et al. Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. , 2012, Radiology.
[30] C. McCollough,et al. Applications of dual-energy CT in urologic imaging: an update. , 2012, Radiologic clinics of North America.
[31] Andrew D. Smith,et al. Bosniak category IIF and III cystic renal lesions: outcomes and associations. , 2012, Radiology.
[32] Xiaozhi Zhao,et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients , 2012, Abdominal Radiology.
[33] M. B. Taylor,et al. Is dual-phase abdominal CT necessary for the optimal detection of metastases from renal cell carcinoma? , 2011, Clinical radiology.
[34] C. Kim,et al. Assessment of renal lesions with blood oxygenation level-dependent MRI at 3 T: preliminary experience. , 2011, AJR. American journal of roentgenology.
[35] Adam B. Shrewsberry,et al. Intra-tumor Doppler flow patterns do not predict malignancy of renal masses in a United States population. , 2011, The Canadian journal of urology.
[36] E. Merkle,et al. Detection of renal lesion enhancement with dual-energy multidetector CT. , 2011, Radiology.
[37] Danny C. Kim,et al. Contemporary Imaging of the Renal Mass , 2011, Current urology reports.
[38] A. Haliloğlu,et al. Urinary ultrasonography in screening incidental renal cell carcinoma: is it obligatory? , 2011, International Urology and Nephrology.
[39] W. Kong,et al. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? , 2011, Abdominal Imaging.
[40] C. de Bazelaire,et al. Hereditary renal cancer syndromes: an update of a systematic review. , 2010, European urology.
[41] Aitao Guo,et al. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. , 2010, Radiology.
[42] Rakesh Kumar,et al. Role of FDG PET-CT in recurrent renal cell carcinoma , 2010, Nuclear medicine communications.
[43] K. Horton,et al. How not to miss or mischaracterize a renal cell carcinoma: protocols, pearls, and pitfalls. , 2010, AJR. American journal of roentgenology.
[44] M. Stifelman,et al. Bosniak category IIF designation and surgery for complex renal cysts. , 2009, The Journal of urology.
[45] Christianne Leidecker,et al. Dual-energy CT in patients suspected of having renal masses: can virtual nonenhanced images replace true nonenhanced images? , 2009, Radiology.
[46] P. Choyke,et al. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease. , 2009, Clinical radiology.
[47] Bachir Taouli,et al. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. , 2009, Radiology.
[48] G. Israel,et al. Pitfalls in renal mass evaluation and how to avoid them. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[49] Nathan Lawrentschuk,et al. Renal cell carcinoma: imaging and therapy , 2007, Current opinion in urology.
[50] Ari I. Jonisch,et al. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT? , 2007, Radiology.
[51] J. Humm,et al. Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. , 2007, The Lancet. Oncology.
[52] A. Scott,et al. A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma. , 2007, Cancer immunity.
[53] Jeong Kon Kim,et al. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. , 2006, Radiology.
[54] G. Israel,et al. How I do it: evaluating renal masses. , 2005, Radiology.
[55] A. Ruppert-Kohlmayr,et al. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. , 2004, AJR. American journal of roentgenology.
[56] F. Debruyne,et al. Radiolabeled monoclonal antibody G250 in renal-cell carcinoma , 2004, World Journal of Urology.
[57] Steve Horvath,et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[58] Kyoung-Sik Cho,et al. Differentiation of subtypes of renal cell carcinoma on helical CT scans. , 2002, AJR. American journal of roentgenology.
[59] R. Oyen,et al. Diffusion-weighted MR imaging in the evaluation of renal infection: preliminary results. , 2002, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.
[60] W. Kaelin,et al. Von Hippel-Lindau disease. , 2007, Annual review of pathology.
[61] E. Grabbe,et al. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. , 1997, AJR. American journal of roentgenology.
[62] M. Abu-Yousef,et al. Accuracy of color Doppler sonography in assessing venous thrombus extension in renal cell carcinoma. , 1997, AJR. American journal of roentgenology.
[63] P. Choyke,et al. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. , 1996, Radiology.
[64] N. Bander,et al. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] M. Roubidoux,et al. Renal carcinoma: detection of venous extension with gradient-echo MR imaging. , 1992, Radiology.
[66] P. Choyke. MR imaging in renal cell carcinoma. , 1988, Radiology.
[67] P. Carroll,et al. Detection and staging of renal neoplasms: a reassessment of MR imaging. , 1988, Radiology.
[68] W. Yuh,et al. Hippel-Lindau disease: MR imaging. , 1988, Radiology.
[69] M. Bosniak,et al. The current radiological approach to renal cysts. , 1986, Radiology.
[70] P. Choyke,et al. Focal renal masses: magnetic resonance imaging. , 1984, Radiology.